samedan logo

 
 
spacer
home > ebr > spring 2003 > biotech's northern alliance gaining ground
PUBLICATIONS
European Biopharmaceutical Review

Biotech's Northern Alliance Gaining Ground

Denmark and Sweden haven't always got along - the two countries spent much of the 17th Century fighting it out to enlarge their kingdoms. One particularly cold winter, when the narrow stretch of water between the two countries (the Øresund) froze up, the Swedes seized the moment and sent armed horsemen across the ice to pay an unfriendly visit.

Things have settled down since then - the Øresund was bridged three years ago and no armies have marched across it yet. In fact, the bridge reflects a new understanding between the two old foes that they are better off joining forces, not least to attract international business. Today, two bi-national investment groups, Copenhagen Capacity and Position Skåne, are busy promoting greater Copenhagen and Sweden's Skåne region as a single enterprise zone. They have dubbed the region 'Medicon Valley' to attract the interest of one of their prime industry targets: life science.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Hal Grey, Freelance Journalist

Hal Grey is an American freelance journalist and Marketing Consultant living in Copenhagen. He has worked for several Danish firms in international marketing and communications positions, and in advertising and public relations in the United States.

He holds a Master's degree in Journalism from Columbia University, New York.

spacer
Hal Grey
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

New Report Introduces Benchmarks on Clinical Trials Vendor Qualification Process

PRINCETON, NJ – A new report from Tufts Center for the Study of Drug Development establishes benchmarks for the vendor qualification process, a critical element of clinical trial set up and execution. According to its November/December Impact Report, the process volume and complexity of the vendor qualification process creates delays in initiation in 7% of clinical trials for biopharma sponsors and 14% of trials for Contract Research Organizations.
More info >>

White Papers

Securing the Global Pharmaceutical Supply Chain against the Threat of Counterfeit Drugs

World Courier

With a fully integrated GxP-compliant transport, storage and distribution system in place and over 140 wholly owned ISO 9001 - certified offices in more than 50 countries, WORLD COURIER, an AmerisourceBergen® company, is the world’s largest and most experienced provider of specialty courier services. It is uniquely positioned to meet the most demanding industry requirements for managing the global distribution of time - and temperaturesensitive pharmaceutical products and IMPs used commercially or in clinical trials.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement